SUOX: A Potential Drug Target Or Biomarker (G6821)

Target Name: SUOX

NCBI ID: G6821

SUOX

SUOX: A Potential Drug Target Or Biomarker

sulfite oxidase (SUOX) is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and liver. It is a critical enzyme that is involved in the detoxification of sulfur compounds, which are naturally occurring in the body. However, high levels of sulfur compounds can be toxic and can cause a range of health problems, including chronic pain, liver damage, and various cancers. As a result, SUOX has become a focus of interest for researchers as a potential drug target or biomarker.

The structure and function of SUOX

SUOX is a single-chain protein that contains 216 amino acids. It has a molecular weight of 34 kDa and a pre-protein cleavage site at its N-terminus. The protein has a distinct N-terminal transmembrane region that is responsible for its localization to the endoplasmic reticulum and for its interactions with other proteins. The transmembrane region is characterized by the presence of a long N-terminal region that is involved in the formation of a disulfide bond, as well as a short C-terminal region that is involved in the formation of a cation-protein interaction.

SUOX is involved in the detoxification of sulfur compounds, which are naturally occurring in the body. These compounds include homocysteine, which is a metabolite that is produced when the amino acid cysteine 鈥嬧?媔s broken down by the enzyme cysteine 鈥嬧?媝rotease. Other sulfur compounds that can be detoxified by SUOX include cysteine, mercaptan, and arginine.

The activity of SUOX is regulated by various chemical and environmental factors, including pH, temperature, and the presence of other proteins. For example, SUOX activity is enhanced in acidic environments, such as the lungs, and is inhibited in alkaline environments, such as the kidneys. The activity of SUOX can also be influenced by the presence of other proteins, such as NAD+, which is a cofactor for the enzyme.

Drug targeting and biomarker potential

SUOX has been identified as a potential drug target due to its involvement in the detoxification of sulfur compounds, which can be toxic and cause various health problems. Researchers are interested in using small molecules or antibodies to inhibit the activity of SUOX and to reduce the production of homocysteine. This approach could be used to treat a range of conditions, including chronic pain, liver damage, and various cancers.

Another potential use of SUOX as a biomarker is its ability to be expressed and detected in various tissues and organs, making it a potential marker for tracking the effectiveness of therapeutic interventions. For example, if an inhibitor of SUOX is administered to a patient, the levels of SUOX in the patient's tissues and organs can be measured to determine if the inhibitor is having the desired effect. This approach could be used to monitor the effectiveness of various therapeutic interventions, including medications, toxins, and radiation treatments.

Conclusion

SUOX is a protein that is involved in the detoxification of sulfur compounds, which can be toxic and cause various health problems. As a result,SUOX has become a focus of interest for researchers as a potential drug target or biomarker. The activity of SUOX is regulated by various chemical and environmental factors, and it can be influenced by the presence of other proteins. The potential use of SUOX as a drug target or biomarker is an exciting area of 鈥嬧?媟esearch, with potential applications in the treatment of a range of conditions.

Protein Name: Sulfite Oxidase

Functions: Catalyzes the oxidation of sulfite to sulfate, the terminal reaction in the oxidative degradation of sulfur-containing amino acids

The "SUOX Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SUOX comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets